Background: Bariatric surgery leads to weight loss and to cardiometabolic risk improvement. Although prediabetes remission after bariatric surgery is biologically plausible, data on this topic is scarce. We aimed to assess prediabetes remission rate and clinical predictors of remission in a 4 year follow up period.

Methods: Observational longitudinal study including patients with obesity and prediabetes who had undergone bariatric surgery in our centre. Prediabetes was defined as having a baseline glycated haemoglobin (A1c) between 5.7% and 6.4% and absence of anti-diabetic drug treatment. We used logistic regression models to evaluate the association between the predictors and prediabetes remission rate.

Results: A total of 669 patients were included, 84% being female. The population had a mean age of 45.4 ± 10.1 years-old, body mass index of 43.8 ± 5.7 kg/m, and median A1c of 5.9 [5.8, 6.1]%. After bariatric surgery, prediabetes remission rate was 82%, 73%, 66%, and 58%, respectively in the 1st, 2nd, 3rd, and 4th years of follow-up. Gastric sleeve (GS) surgery was associated with higher prediabetes remission rate than Roux-en-Y gastric bypass surgery in the 3rd year of follow-up. Men had a higher remission rate than women, in the 1st and 3nd years of follow-up in the unadjusted analysis. Younger patients presented a higher remission rate comparing to older patients in the 3rd year of follow-up.

Conclusion: We showed a high prediabetes remission rate after bariatric surgery. The remission rate decreases over the follow-up period, although most of the patients maintain the normoglycemia. Prediabetes remission seems to be more significant in patients who had undergone GS, in male and in younger patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10782579PMC
http://dx.doi.org/10.1186/s12902-024-01537-0DOI Listing

Publication Analysis

Top Keywords

prediabetes remission
32
remission rate
28
bariatric surgery
24
remission
11
prediabetes
10
remission bariatric
8
surgery
8
years follow-up
8
3rd year
8
higher remission
8

Similar Publications

Objective: Progression of prediabetes to type 2 diabetes has been associated with β-cell dysfunction, whereas its remission to normoglycemia has been related to improvement of insulin sensitivity. To understand the mechanisms and identify potential biomarkers related to prediabetes trajectories, we compared the proteomics and metabolomics profile of people with prediabetes progressing to diabetes or reversing to normoglycemia within 1 year.

Research Design And Methods: The fasting plasma concentrations of 1,389 proteins and the fasting, 30-min, and 120-min post-oral glucose tolerance test (OGTT) plasma concentrations of 152 metabolites were measured in up to 134 individuals with new-onset diabetes, prediabetes, or normal glucose tolerance.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines a new healthcare model in New Zealand that combines a low-carbohydrate diet and health coaching to help manage prediabetes and Type 2 diabetes.
  • Participants reported health benefits like weight loss and increased energy, while also facing challenges such as resistance from some healthcare providers and misconceptions about low-carb diets.
  • The model shows promise for improving patient outcomes and reducing the workload on healthcare professionals, though further education and awareness are needed for wider adoption.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiac rehabilitation programs can help patients with atherosclerotic cardiovascular diseases (ASCVD) adopt healthier lifestyles, but there’s a need to explore strategies for reversing conditions like prediabetes and metabolic syndrome.
  • The DIABEPIC-1 study evaluated a 6-month enhanced rehabilitation program combining exercise with nutritional interventions, such as a Mediterranean diet and reduced ultraprocessed food intake.
  • Results showed high participation rates and significant health improvements, with half of the participants achieving prediabetes remission and 70% with metabolic syndrome also reaching remission by the end of the study.
View Article and Find Full Text PDF

Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study.

Eur J Cancer

December 2024

Department of Healthcare Administration and Policy, School of Public Health, University of Nevada, Las Vegas, USA.

Background & Aims: Hyperglycemia is associated with an increased risk of gallbladder cancer (GBC), potentially by inhibiting gallbladder motility and inducing prolonged cholestasis. Although intermediate hyperglycemia (or prediabetes) is highly reversible, evidence is lacking about whether prediabetes persistence or remission is associated with an altered GBC risk.

Methods: This nationwide cohort study included 6058,662 adults without diabetes or cancer who underwent national health examinations twice in 2-year intervals between 2009 (S1) and 2011 (S2) and were followed-up until 2018.

View Article and Find Full Text PDF

Objective: The objective of this expert consensus process was to define performance measures that can be used to document remission or long-term progress following lifestyle medicine (LM) treatment.

Methods: Expert panel members with experience in intensive, therapeutic lifestyle change (ITLC) developed a list of performance measures for key disease states, using an established process for developing consensus statements adapted for the topic. Proposed performance measures were assessed for consensus using a modified Delphi process.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!